Moore John R

Edgewise Therapeutics, Inc. · General Counsel

Moore John R is listed in public filings as officer: General Counsel. This Moore John R insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Edgewise Therapeutics, Inc. (EWTX). Investors use Moore John R's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Edgewise Therapeutics, Inc.EWTX$2.2M161.3k sharesGrant / ExerciseAug 12, 2025$2.2M161.3k shares$13.39--
Edgewise Therapeutics, Inc.EWTX--12.3k sharesGrant / ExerciseAug 12, 2025Disclosure amount unavailable5.8k shares----
Edgewise Therapeutics, Inc.EWTX--26.9k sharesGrant / ExerciseAug 12, 2025Disclosure amount unavailable26.9k shares----
Edgewise Therapeutics, Inc.EWTX$137k10.2k sharesSellAug 12, 2025$28.1K2.1k shares$13.39--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Edgewise Therapeutics, Inc.EWTX$107k6.5k sharesSellMay 2, 2025$31.8K1.9k shares$16.45--
Edgewise Therapeutics, Inc.EWTX--5.2k sharesGrant / ExerciseMay 1, 2025Disclosure amount unavailable5.2k shares----
Edgewise Therapeutics, Inc.EWTX$90k3.3k sharesSellSep 23, 2024$578.1K20.9k shares$27.63--
Edgewise Therapeutics, Inc.EWTX$17k24.2k sharesGrant / ExerciseSep 23, 2024$14.9K20.9k shares$0.71--
Edgewise Therapeutics, Inc.EWTX$92k3.3k sharesSellSep 20, 2024$1.4M50k shares$28.37--
Edgewise Therapeutics, Inc.EWTX$38k53.3k sharesGrant / ExerciseSep 20, 2024$35.5K50k shares$0.71--
Edgewise Therapeutics, Inc.EWTX$2.4M138.8k sharesGrant / ExerciseAug 12, 2024$2.4M138.8k shares$17.05--
Edgewise Therapeutics, Inc.EWTX--23.1k sharesGrant / ExerciseAug 12, 2024Disclosure amount unavailable23.1k shares----